Full Text View
Tabular View
No Study Results Posted
Related Studies
Hemodynamic Effects of Chronic Administration of Spironolactone and/or Propranolol in Alcoholic Cirrhotic Patients
This study has been terminated.
Study NCT00188045   Information provided by University Hospital, Angers
First Received: September 12, 2005   Last Updated: December 28, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Alcoholic Cirrhosis
Additional conditions recognized in this trial
Fibrosis
Liver Cirrhosis
Liver Cirrhosis, Alcoholic
More general conditions related to this trial
Alcohol-Induced Disorders
Alcohol-Related Disorders
Digestive System Diseases
Disorders of Environmental Origin
Liver Diseases
Liver Diseases, Alcoholic
Pathologic Processes
Substance-Related Disorders
Interventions listed in this trial
Propranolol - Spironolactone
Additional drug interventions recognized in this trial
Propranolol
Spironolactone
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Antagonists
Adrenergic beta-Antagonists
Aldosterone Antagonists
Anti-Arrhythmia Agents
Antihypertensive Agents
Cardiovascular Agents
Diuretics
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
University Hospital, Angers


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services